Rapport Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 7 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -477.00 | 67.00 | 459.00 | 138.00 | |||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -292.00 | -388.00 | -423.00 | 626.00 | 253.00 | 4.00 | -743.00 |
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -538.00 | 165.00 | 603.00 | 198.00 | |||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -401.00 | -469.00 | -499.00 | 830.00 | 302.00 | -31.00 | -904.00 |
| Return on Sales [ROS] (QoQ)ROS (QoQ) | -64650.00 |